These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 4008986)
1. Rhesus diploid rabies vaccine (adsorbed): a new rabies vaccine using FRhL-2 cells. Burgoyne GH; Kajiya KD; Brown DW; Mitchell JR J Infect Dis; 1985 Jul; 152(1):204-10. PubMed ID: 4008986 [TBL] [Abstract][Full Text] [Related]
2. Essential Role of T cells in the postexposure prophylaxis of rabies in mice. Mifune K; Takeuchi E; Napiorkowski PA; Yamada A; Sakamoto K Microbiol Immunol; 1981; 25(9):895-904. PubMed ID: 6171709 [TBL] [Abstract][Full Text] [Related]
3. [Rabies specific IgM- and IgG-antibody response in persons immunized with HDCS vaccine according to the Essen postexposure vaccination schedule (author's transl)]. Thraenhart O; Kuwert EK Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):429-41. PubMed ID: 44937 [TBL] [Abstract][Full Text] [Related]
4. Rhesus diploid rabies vaccine (adsorbed), a new rabies vaccine. II. Results of clinical studies simulating prophylactic therapy for rabies exposure. Berlin BS; Mitchell JR; Burgoyne GH; Brown WE; Goswick C JAMA; 1983 May; 249(19):2663-5. PubMed ID: 6341639 [TBL] [Abstract][Full Text] [Related]
5. Rabies vaccine prepared from the virus grown in Japanese quail embryo cell cultures. Bektemirova MS; Pille ER; Matevosyan KS; Nagieva FG Acta Virol; 1983 Jan; 27(1):59-64. PubMed ID: 6133431 [TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine. Turner GS J Gen Virol; 1978 Sep; 40(3):595-604. PubMed ID: 690611 [TBL] [Abstract][Full Text] [Related]
7. Multisite intradermal antirabies vaccination. Immune responses in man and protection of rabbits against death from street virus by postexposure administration of human diploid-cell-strain rabies vaccine. Nicholson KG; Prestage H; Cole PJ; Turner GS; Bauer SP Lancet; 1981 Oct; 2(8252):915-8. PubMed ID: 6117693 [TBL] [Abstract][Full Text] [Related]
9. Rhesus diploid rabies vaccine (adsorbed), a new rabies vaccine. Results of initial clinical studies of preexposure vaccination. Berlin BS; Mitchell JR; Burgoyne GH; Oleson D; Brown WE; Goswick C; McCullough NB JAMA; 1982 Mar; 247(12):1726-8. PubMed ID: 7038159 [TBL] [Abstract][Full Text] [Related]
10. Enhanced antibody responses in mice by combined administration of interferon with rabies vaccine. Mifune K; Mannen K; Cho S; Narahara H Arch Virol; 1987; 94(3-4):287-95. PubMed ID: 3579612 [TBL] [Abstract][Full Text] [Related]
11. Immunization against rabies with rabies immune globulin, human (RIGH) and a human diploid cell strain (HDCS) rabies vaccine. Kuwert EK; Werner J; Marcus I; Cabasso VJ J Biol Stand; 1978 Jul; 6(3):211-9. PubMed ID: 721838 [No Abstract] [Full Text] [Related]
12. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment. Vodopija I; Sureau P; Smerdel S; Lafon M; Baklaić Z; Ljubicić M; Svjetlicić M Vaccine; 1988 Jun; 6(3):283-6. PubMed ID: 3420976 [TBL] [Abstract][Full Text] [Related]
13. Rabies postexposure prophylaxis with human diploid cell rabies vaccine: lower neutralizing antibody titers with Wyeth vaccine. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1985 Feb; 34(7):90-2. PubMed ID: 3918250 [No Abstract] [Full Text] [Related]
14. Leads from the MMWR. Rabies postexposure prophylaxis with human diploid cell rabies vaccine: lower neutralizing antibody titers with Wyeth vaccine. JAMA; 1985 Mar; 253(11):1537, 1540. PubMed ID: 3974025 [No Abstract] [Full Text] [Related]
15. Reduction in the dosage schedule of BPL-inactivated neural tissue vaccine for rabies prophylaxis in man. Tripathi KK; Madhusudana SN; Sahu A Indian J Med Res; 1990 Sep; 91():334-9. PubMed ID: 2269504 [TBL] [Abstract][Full Text] [Related]
16. Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers. Lodmell DL; Parnell MJ; Bailey JR; Ewalt LC; Hanlon CA Vaccine; 2002 May; 20(17-18):2221-8. PubMed ID: 12009276 [TBL] [Abstract][Full Text] [Related]
17. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. Manning SE; Rupprecht CE; Fishbein D; Hanlon CA; Lumlertdacha B; Guerra M; Meltzer MI; Dhankhar P; Vaidya SA; Jenkins SR; Sun B; Hull HF; MMWR Recomm Rep; 2008 May; 57(RR-3):1-28. PubMed ID: 18496505 [TBL] [Abstract][Full Text] [Related]
18. Protection of dogs against death from experimental rabies by postexposure administration of rabies vaccine and hyperimmune globulin (human). Cho HC; Lawson KF Can J Vet Res; 1989 Oct; 53(4):434-7. PubMed ID: 2590870 [TBL] [Abstract][Full Text] [Related]
19. Immune response to rabies booster vaccination in subjects who had postexposure treatment more than 5 years previously. Naraporn N; Khawplod P; Limsuwan K; Thipkong P; Herzog C; Glueck R; Tantawichien T; Wilde H J Travel Med; 1999 Jun; 6(2):134-6. PubMed ID: 10381966 [No Abstract] [Full Text] [Related]
20. Antibody response to a single intradermal booster dose of rabies human diploid cell vaccine. Dreesen DW; Kemp DT; Brown J; Brown WJ J Am Vet Med Assoc; 1983 Dec; 183(12):1468-70. PubMed ID: 6654729 [No Abstract] [Full Text] [Related] [Next] [New Search]